Condition: Osteosarcoma · Pulmonary Recurrence of Osteosarcoma · Sponsor: Emory University
This study aims to determine the safety and tolerability of combined Atezolizumab, stereotactic body radiation therapy (SBRT), and surgical resection of pulmonary metastases in patients with pulmonary recurrence of osteosarcoma
This description comes directly from the study's public registry record.
Thomas Cash, MD, MSc · 404-785-0910 · aflacdevtreferral@choa.org
Melissa Schink · DevTcoordinators@choa.org
Always discuss trial participation with your own doctor first.
| Chilldren's Healthcare of Atlanta | Atlanta, Georgia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06492954